Leerink Partners Downgrades NeuroPace to Market Perform, Announces $7 Price Target

Benzinga · 2d ago
Leerink Partners analyst Mike Kratky downgrades NeuroPace (NASDAQ:NPCE) from Outperform to Market Perform and announces $7 price target.